Medtronic spinal cord stimulation (SCS) offers a non-opioid, FDA approved alternative when other chronic pain treatments have failed, such as:
SCS disrupts the pain signals traveling between the spinal cord and the brain. Stimulation is delivered by a neurostimulator — a device similar to a pacemaker — implanted under the skin.
The impulses travel from the device to the spine over thin insulated wires called leads.
DTM™ SCS therapy is a proprietary therapy only proven on the Intellis™ system, with superior technology that supports multiple therapy options to meet the needs of individual patients.
DTM Spinal Cord Stimulation Overview - (03:12)
DTM spinal cord stimulation is proven to be superior to conventional stimulation. Learn about the risks and benefits.
More information (see more) Less information (see less)
A recent clinical study of DTM™ SCS demonstrated superior back pain relief compared to conventional stimulation at 3 months after a permanent implant (94 implanted patients)1. At 12 months follow-up, the study also showed:
Under specific conditions. Talk to your doctor and refer to product labeling for full list of conditions.
For more information on our 9-year INS limited warranty, contact email@example.com
Fishman M, Cordner H, et al. DTM™ SCS RCT 12-month Data Results. Presented at a Medtronic webinar, jointly supported by the North American Neuromodulation Society (NANS), World Institute of Pain(WIP), and the American Society for Pain and Neuroscience (ASPN). October 19, 2020. Webinar available on society websites.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.